R.H. Bluestein & Co’s Enovis ENOV Stock Holding History

R.H. Bluestein & Co’s Portfolio ENOV Stock Details ENOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-1,801	Closed	-$231K	–	366
2014 Q2	$231K	Sell	1,801 -523	-23%	-$65.3K	0.01%	323
2014 Q1	$285K	Sell	2,324 -1,162	-33%	-$133K	0.02%	288
2013 Q4	$382K	Buy	+3,486	New	+$349K	0.02%	227

Other funds holding ENOV

BCP

BDT Capital Partners Chicago, Illinois $3.51B AUM 31.02% 1-Year Est. Return

JHIU

Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return

BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return

ACM

AKRE Capital Management Middleburg, Virginia $6.13B AUM 15.27% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tiger Global Management New York $22.8B AUM 30.07% 1-Year Est. Return

BRC

Blue Ridge Capital New York $215M AUM

Hound Partners New York $799M AUM 9.54% 1-Year Est. Return

R.H. Bluestein & Co's ENOV Position: Q3 2014 in Review

R.H. Bluestein & Co sold out of Enovis (ENOV) in Q3 2014, closing a stake of 1,801 shares — an estimated $231K sold.

R.H. Bluestein & Co first reported a position in ENOV in Q4 2013 and held it in 3 quarters. The position peaked at $382K in Q4 2013. 211 funds tracked by Wall St. Rank hold ENOV as of Q3 2014.

R.H. Bluestein & Co reported no remaining Enovis position as of Q3 2014 after selling out during the quarter.
R.H. Bluestein & Co sold 1,801 Enovis shares in Q3 2014, an estimated $231K.
R.H. Bluestein & Co first reported a position in Enovis in Q4 2013 and held it in 3 quarters.
R.H. Bluestein & Co's Enovis position peaked at $382K in Q4 2013.
211 funds tracked by Wall St. Rank held Enovis as of Q3 2014.

Based on R.H. Bluestein & Co's 13F filing for Q3 2014, filed 12 Nov 2014.